Bevacizumab for Malignant Brain Gliomas. Which is the Current Evidence?

E-ISSN： 2212-2710|9|2|136-143

ISSN： 1872-213X

Source： Recent Patents on Inflammation & Allergy Drug Discovery, Vol.9, Iss.2, 2015-08, pp. : 136-143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Has Bevacizumab (Avastin) Given Extra Therapeutic Gain in Metastatic Colorectal Cancer and Malignant Brain Gliomas? Systematic Review Answering this Question

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 6, Iss. 1, 2012-01 ,pp. : 70-77

Bentham Science Publishers

Access to resources Recommend Favorite

Nanoparticle-based Cerebral Drug-Delivery Systems and Antiangiogenic Approach in Gliomas Treatment

Recent Patents on Nanotechnology, Vol. 5, Iss. 3, 2011-11 ,pp. : 239-244

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the Management of Malignant Hemopathies: The Role of Statins

Recent Patents on DNA & Gene Sequences, Vol. 7, Iss. 1, 2013-04 ,pp. : 57-61

Bentham Science Publishers

Access to resources Recommend Favorite

Current problems in fundamental metrology

By Bronnikov K.

Measurement Techniques, Vol. 53, Iss. 4, 2010-08 ,pp. : 391-401

Springer Publishing Company

Access to resources Recommend Favorite

Current Events in Europe

By Bacivarof Ioan

Quality Engineering, Vol. 14, Iss. 1, 2002-01 ,pp. : 171-175

Taylor & Francis Ltd

Access to resources Recommend Favorite